# Traitement du cancer du sein HER2-positif 
 Options thérapeutiques : Tucatinib, Trastuzumab deruxtecan.

This page does not yet have an agent-readable markdown version.
Canonical: https://diagnosticdetectives.com/products/her2-positive-breast-cancer-therapy-tucatinib-trastuzumab-deruxtecan-4